Eli Lilly
$1172.27-6.84Capitalisation boursière
$1.05T
Rang mondial
#13
Sommet historique
$1.10T
2026-07-07
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 96% of the 367 companies we track (globally).
- Equivalent to 3.4% of United States's GDP (2025 data).
- Just above: #12 Samsung Electronics ($1.14T)
- Just below: #14 JPMorgan Chase ($959.5B)
- Best year: 1997 (+94%). Worst year: 1999 (-24%).
Eli Lilly Financial Breakdown (FY 2025)
Source: Yahoo Finance — LLY annual filings (2025) →$65.2B revenue · $29.7B operating income · $20.6B net income
- ●Operating margin: 45.6% on $65.2B in revenue.
- ●R&D is 20.5% of revenue ($13.3B).
- ●Net income margin: 31.7% — $20.6B in profit.
- ●Free cash flow: $6.0B (9.2% of revenue).
Cost / Operating Expenses
Total operating expenses $35.5B
Total
$35.5B
Capital Expenditures
$10.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$6.0B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
—
EPS
—
Net margin
—
ROE
—
Dividend yield
—
Debt / Equity
—
À propos de Eli Lilly
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
Historique de la capitalisation boursière de Eli Lilly (2026–2026)
Eli Lilly vs Sector Peers by Market Cap
Comparer Eli Lilly
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $1.05T | #13(↓2) | +10.4% |
| 2025 | $955.1B | #11(↑1) | +40.2% |
| 2024 | $681.0B | #12(↓1) | +33.3% |
| 2023 | $510.9B | #11(↑8) | +60.9% |
| 2022 | $317.5B | #19(↑16) | +34.3% |
| 2021 | $236.5B | #35(↑17) | +66.1% |
| 2020 | $142.4B | #52(↑10) | +31.0% |
| 2019 | $108.7B | #62(↓12) | +16.1% |
| 2018 | $93.6B | #50(↑23) | +40.5% |
| 2017 | $66.6B | #73 | +17.8% |
| 2016 | $56.5B | #73(↓11) | -10.4% |
| 2015 | $63.1B | #62(↑9) | +25.4% |
| 2014 | $50.3B | #71(↑24) | +39.8% |
| 2013 | $36.0B | #95(↓23) | +7.3% |
| 2012 | $33.5B | #72(↑2) | +24.2% |
| 2011 | $27.0B | #74(↑33) | +25.2% |
| 2010 | $21.6B | #107(↓18) | +3.7% |
| 2009 | $20.8B | #89(↓28) | -6.2% |
| 2008 | $22.2B | #61(↑17) | -21.3% |
| 2007 | $28.2B | #78(↓13) | +5.7% |
| 2006 | $26.7B | #65(↓10) | -5.2% |
| 2005 | $28.1B | #55(↓10) | +2.5% |
| 2004 | $27.5B | #45(↓13) | -17.5% |
| 2003 | $33.3B | #32(↓2) | +13.1% |
| 2002 | $29.4B | #30 | -17.6% |
| 2001 | $35.7B | #30(↑2) | -14.4% |
| 2000 | $41.7B | #32(↑9) | +41.9% |
| 1999 | $29.4B | #41(↓15) | -24.2% |
| 1998 | $38.8B | #26(↓2) | +29.1% |
| 1997 | $30.1B | #24(↑12) | +93.5% |
| 1996 | $15.5B | #36(↓6) | +32.7% |
| 1995 | $11.7B | #30(↑1) | +77.3% |
| 1994 | $6.6B | #31 |
Autres entreprises du secteur Santé
FAQ
What is Eli Lilly and Company's market cap?
Eli Lilly and Company (LLY) has a market capitalization of $1.05T, making it the #13 largest company in the world by market cap.
What was Eli Lilly and Company's highest market cap?
Eli Lilly and Company's all-time high market cap was $1.10T, reached in 2026-07-07. Its highest rank was #13 in 2026.
What sector is Eli Lilly and Company in?
Eli Lilly and Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Eli Lilly and Company's market cap changed over time?
Eli Lilly and Company has been tracked since 2026. Its market cap has grown by 0% from $1.05T in 2026 to $1.05T today.